Cash, Cash Equivalents, and Marketable Securities
Morgan Stanley Cash, Cash Equivalents, and Marketable Securities decreased by 43.7% to $30.79B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 51.5%, from $63.49B to $30.79B. Over 4 years (FY 2021 to FY 2025), Cash, Cash Equivalents, and Marketable Securities shows a downward trend with a -26.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
Higher levels indicate strong liquidity and financial health, while lower levels may signal a need for external financing.
Detailed definition
This represents the most liquid assets held by the company, including cash on hand, bank deposits, and short-term invest...
Peer comparison
A standard liquidity metric reported by virtually all public companies on the balance sheet.
cash_equivalents_marketable_securities_totalHistorical Data
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $102.83B | $72.12B | $77.56B | $81.96B | $83.12B | $75.46B | $70.88B | $67.88B | $77.16B | $61.70B | $68.48B | $72.37B | $63.49B | $52.42B | $71.05B | $54.69B | $30.79B |
| QoQ Change | — | -29.9% | +7.5% | +5.7% | +1.4% | -9.2% | -6.1% | -4.2% | +13.7% | -20.0% | +11.0% | +5.7% | -12.3% | -17.4% | +35.5% | -23.0% | -43.7% |
| YoY Change | — | — | — | — | -19.2% | +4.6% | -8.6% | -17.2% | -7.2% | -18.2% | -3.4% | +6.6% | -17.7% | -15.0% | +3.8% | -24.4% | -51.5% |
Cash, Cash Equivalents, and Marketable Securities at Other Companies
Frequently Asked Questions
- What is Morgan Stanley's cash, cash equivalents, and marketable securities?
- Morgan Stanley (MS) reported cash, cash equivalents, and marketable securities of $30.79B in Q4 2025.
- How has Morgan Stanley's cash, cash equivalents, and marketable securities changed year-over-year?
- Morgan Stanley's cash, cash equivalents, and marketable securities decreased by 51.5% year-over-year, from $63.49B to $30.79B.
- What is the long-term trend for Morgan Stanley's cash, cash equivalents, and marketable securities?
- Over 4 years (2021 to 2025), Morgan Stanley's cash, cash equivalents, and marketable securities has grown at a -26.0% compound annual growth rate (CAGR), from $102.83B to $30.79B.
- What does cash, cash equivalents, and marketable securities mean?
- The total value of the company's cash and highly liquid short-term investments.